About this trial
To aim of the EXPOSURE study is to investigate the effects of epicardial fat on cardiac function, pericardial constraint and pulmonary artery vasodilatation using cardiac magnetic resonance (CMR) imaging at rest and during exercise stress testing in patients with HFpEF.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Signs and symptoms of HF according to the Europeans Society of Cardiology guideline.
LV ejection fraction ≥40%.
HFA-PEFF score ≥5 or HFA-PEFF score 2-4 in combination with positive stress test (Figure 1).
>18 years of age
Disqualifiers
Body weight >140 kg
Atrial fibrillation or other significant arrhythmia during the assessment
Contraindications for CMR (e.g. claustrophobia, implanted cardiac devices)
Myocardial infarction, percutaneous coronary intervention or coronary artery bypass graft <3 months or untreated severe obstructive coronary artery stenosis
Trial population
A cohort of 50 patients with HFpEF, in which the effects of epicardial fat on cardiac function, pericardial constraint and pulmonary artery vasodilatation will be tested using cardiac magnetic resonance (CMR) imaging at rest and during exercise stress testing.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Ventricular interdependence
the effect of epicardial fat on ventricular interdependence at peak exercise
Secondary outcomes
VO2-max
the effect of epicardial fat on VO2-max at peak exercise
LV/RV diastolic strain rate
the effect of epicardial fat on ventricular diastolic strain rate measured on echocardiography at peak exercise
slope of early LV/RV filling
the effect of epicardial fat on slope of early ventricular filling measured on echocardiography at peak exercise
left and right atrial reservoir strain
the effect of epicardial fat on atrial emptying fraction measured on echocardiography at peak exercise
Sponsors and contacts
Click on the lead sponsor to view all of their trials.